Role of Orlistat in the Treatment of Obese Patients With Type 2 Diabetes: A 1-year randomized double-blind study

A Hollander, Priscilla; C Elbein, Steven; B Hirsch, Irl; Kelley, David; McGill, Janet; Taylor, Terry; R Weiss, Stuart; E Crockett, Samuel; A Kaplan, Roy; Comstock, John; P Lucas, Charles; A Lodewick, Peter; Canovatchel, William; Chung, Jain; Hauptman, Jonathan

doi:10.2337/diacare.21.8.1288

Public

Role of Orlistat in the Treatment of Obese Patients With Type 2 Diabetes: A 1-year randomized double-blind study

Shared by NobleBlocks on Aug 1, 1998 • 12:00 AM UTC

Authors:

Priscilla A Hollander

Steven C Elbein

Irl B Hirsch

Abstract

OBJECTIVE Obesity is an important risk factor for type 2 diabetes. Weight loss in patients with type 2 diabetes is associated with improved glycemic control and reduced cardiovascular disease risk factors, but weight loss is notably difficult to achieve and sustain with caloric restriction and exerc...

Discussions